23andme Case Summary

Satisfactory Essays

In this article Megan Molteni goes into detail about the company 23ANDME and its new business plan to both increase the company’s profit while helping combat genetic disease such as Parkinson. Recently 23andMe was able to obtain an astonishing $1.75 billion valuation. Which is a very big accomplishment for a tech company. This company was able to make in its fortune by selling spit kits priced at $99 that allow the consumer to see their genetic makeup and ancestry. As well as some information regarding health such as having an increased chance of contracting Parkinson’s disease. In the future 23andMe hopes to give a wider range of information on health risks by identifying the disease carrying genes. The way to make this possible is by turning

Get Access